NeuroDerm is an agile and entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions through Pharma & MedTech integration.
By developing next-generation drug-device combination solutions for central nervous system disorders, we aspire to make a meaningful difference in patients’ lives and drive future healthcare connectivity.
Our mission is to address the challenges of the future healthcare and wellbeing ecosystem. We are passionately driven to reduce disease burden and improve the quality of life of patients and their families through innovative drug-device combination therapies and technologies.
MedRhythms is developing next-generation neurotherapeutics that leverage the power of music and technology to redefine what's possible in brain health, for patients around the world. Our devices are designed to improve walking, mobility and related functional outcomes via a proprietary, patented technology platform. This platform combines sensors, software, and music with advanced neuroscience to target neural circuitry. We are developing a pipeline of digital therapeutics across a range of neurological conditions, including stroke, multiple sclerosis and Parkinson’s disease. For more information about how we are pioneering digital therapeutics, visit https://medrhythms.com/
Neuroglee Therapeutics develops personalized, evidence-based virtual care solutions to treat and manage patients with neurological conditions. Neuroglee’s adaptive learning platform leverages machine learning to dynamically personalize and optimize treatment based on patients’ unique needs. By combining best-in-class cognitive rehabilitation strategies and virtual care management delivered by an experienced, interdisciplinary clinical team, Neuroglee improves patient outcomes, reduces caregiver and clinician burden, and enhances the overall patient experience. Neuroglee also offers a digital therapeutic candidate, NG-001, which may be used as a stand-alone therapy or combined with pharmacotherapy to empower people living with MCI to obtain the highest quality care for preserving cognition and promoting independence. For more information, visit neuroglee.com